Reversing anticoagulation in the hemorrhaging patient

Current Opinion in Anaesthesiology
Benedikt TremlBettina Schenk

Abstract

Anticoagulants in general, but especially the relatively new direct oral anticoagulants and platelet inhibitors, pose a great challenge for physicians in the hemorrhaging patient. The aim of the present review is to provide an overview on recent studies dealing with the reversal of anticoagulation in the hemorrhaging patient and to describe our therapeutic emergency strategy for those patients. A specific antidote for dabigatran is already on the market and antidotes for the direct and indirect factor Xa inhibitors are in development. Moreover, bleeding under platelet inhibitors remains critical with very little evidence on effective reversal strategies. To reverse anticoagulation in the hemorrhaging patient, specific antidotes should be the first option if available, followed by four-factor prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor seven as the emergency strategy. Fibrinogen concentrate, antifibrinolytics and oral charcoal, respectively, can be considered as an additional measure. Massive blood loss and thrombocytopenia should be treated independently according to the respective, local guidelines for (massive) transfusion of blood and blood products.

References

Jan 23, 2008·Journal of Thrombosis and Haemostasis : JTH·I PabingerUNKNOWN Beriplex P/N Anticoagulation Reversal Study Group
Aug 26, 2010·Journal of Thrombosis and Haemostasis : JTH·P PrandoniUNKNOWN RIETE Group
Oct 6, 2010·Analytical and Bioanalytical Chemistry·Mette SchroederKristian B Johansen
Oct 1, 2011·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Joost J van VeenMike Makris
Sep 27, 2012·American Journal of Clinical Pathology·Joyce CurversVolkher Scharnhorst
Dec 12, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Don N ChangAndrew I Chin
Apr 3, 2015·Thrombosis and Haemostasis·Andreas GreinacherKathleen Selleng
May 1, 2015·Archives of Pathology & Laboratory Medicine·João D DiasLaurel A Omert
Jun 23, 2015·The New England Journal of Medicine·Charles V PollackJeffrey I Weitz
Nov 13, 2015·The New England Journal of Medicine·Deborah M SiegalMark A Crowther
Jan 19, 2016·Journal of Thrombosis and Thrombolysis·Allison E BurnettJack Ansell
Aug 31, 2016·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN ANNEXA-4 Investigators
Sep 15, 2016·Blood Reviews·Bethany T Samuelson, Adam Cuker
Oct 30, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Prajwal DhakalVijaya R Bhatt
Dec 6, 2016·Current Pharmaceutical Design·Peter RaimondiKonstantinos N Aronis
Apr 1, 2017·Frontiers in Neurology·Deepak GulatiMichel T Torbey
Apr 2, 2017·The American Journal of Cardiology·Benjamin A SteinbergUNKNOWN Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients
Jul 12, 2017·The New England Journal of Medicine·Charles V PollackJeffrey I Weitz
Sep 2, 2017·Annals of Translational Medicine·Giuseppe LippiEmmanuel J Favaloro
Oct 6, 2017·International Journal of Laboratory Hematology·L SeyveR Marlu
Nov 7, 2017·Journal of Thrombosis and Haemostasis : JTH·J H LevyJ I Weitz
Jan 6, 2018·BMJ : British Medical Journal·Beverley J Hunt, Marcel Levi
Jan 19, 2018·Nature Reviews. Cardiology·Jerrold H LevyJeffrey I Weitz
Feb 13, 2018·The Journal of Surgical Research·Chancey CarothersBrandon Hobbs
Apr 6, 2018·International Journal of Critical Illness and Injury Science·Tara HoltTai Elder
Jun 1, 2018·Clinical Practice and Cases in Emergency Medicine·Jonathan BalakumarMark Supino
Jun 22, 2018·Drugs·Young-A Heo
Jul 4, 2018·Polish Archives of Internal Medicine·Armando TripodiFlora Peyvandi
Jul 5, 2018·Deutsche medizinische Wochenschrift·Björn Alexander HummelHermann Eichler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.